He does a good job of explaining the plaque reversal that was achieved in the recent FLOWPROMOTE randomized trial.
40mg atorvastatin shrank total plaque by 14% in 18 months.
40mg rosuvastatin + 10mg ezetimibe shrank it by 21% in the same time.
This was proven with full before-and-after CT angiography of the coronary arteries.
#statinreverseHD #statinsHD #ezetimibeHD #flowpromoteHD #ezetimibereverseHD #reverseHD
▶


